Literature DB >> 15634813

Molecular and immunohistological characterization of human cartilage two years following autologous cell transplantation.

Brunella Grigolo1, Livia Roseti, Luciana De Franceschi, Anna Piacentini, Luca Cattini, Massimiliano Manfredini, Riccardo Faccini, Andrea Facchini.   

Abstract

BACKGROUND: There are only a few studies concerning the cellular, biochemical, and genetic processes that occur during the remodeling of graft tissue after autologous chondrocyte transplantation. The purpose of the present study was to quantify the expression of genes encoding extracellular matrix proteins and regulatory factors that are essential for cell differentiation in cartilage biopsy specimens from patients who had this treatment two years previously.
METHODS: Two cartilage biopsy specimens from each of four patients who had been treated with autologous chondrocyte transplantation and from two multiorgan donors were used. Real-time reverse transcriptase-polymerase chain reaction analysis was performed to evaluate the expression of types I, II, and X collagen; aggrecan; cathepsin B; and early growth response protein-1 (Egr-1) and Sry-type high-mobility-group box transcription factor-9 (Sox-9) mRNAs. Immunohistochemical analysis for matrix proteins and regulatory proteins was carried out on paraffin-embedded sections.
RESULTS: Type-I collagen mRNA was expressed in all of the samples evaluated. Type-II collagen was present in autologous chondrocyte transplantation samples but at lower levels than in the controls. Type-X collagen messenger was undetectable. Aggrecan mRNA was present in all of the samples at lower levels than in the controls, while cathepsin-B messenger levels were higher and Egr-1 and Sox-9 mRNAs were expressed at lower levels. The immunohistochemical analysis showed slight positivity for type-I collagen in all of the sections. Type-II collagen was found in all of the samples with positivity confined inside the cells, while the controls displayed a positivity that was diffuse in the extracellular matrix. Cathepsin B was slightly positive in all of the samples, while the controls were negative. Egr-1 protein was particularly evident in the areas negative for type-II collagen. Sox-9 was positive in all samples, with evident localization in the superficial and middle layers.
CONCLUSIONS: In biopsy specimens from autologous chondrocyte transplantation tissue at two years, there is evidence of the formation of new tissue, which displays varying degrees of organization with some fibrous and fibrocartilaginous features. Long-term follow-up investigations are needed to verify whether, once all of the remodeling processes are completed, the newly formed tissue will acquire the more typical features of articular cartilage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634813     DOI: 10.2106/JBJS.C.01685

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  12 in total

1.  Potential of exogenous cartilage proteoglycan as a new material for cartilage regeneration.

Authors:  Shusa Ohshika; Yasuyuki Ishibashi; Atsushi Kon; Tomomi Kusumi; Hiroshi Kijima; Satoshi Toh
Journal:  Int Orthop       Date:  2011-08-12       Impact factor: 3.075

2.  Stem cells and biological approaches to treatment of wrist problems.

Authors:  Alphonsus K S Chong; Min He
Journal:  J Wrist Surg       Date:  2013-11

3.  Dual growth factor-releasing nanoparticle/hydrogel system for cartilage tissue engineering.

Authors:  Sung Mook Lim; Se Heang Oh; Hee Hoon Lee; Soon Hong Yuk; Gun Il Im; Jin Ho Lee
Journal:  J Mater Sci Mater Med       Date:  2010-06-25       Impact factor: 3.896

4.  Genetic engineering of juvenile human chondrocytes improves scaffold-free mosaic neocartilage grafts.

Authors:  Vincent Y Ng; Seth S Jump; Kelly S Santangelo; Duncan S Russell; Alicia L Bertone
Journal:  Clin Orthop Relat Res       Date:  2012-09-25       Impact factor: 4.176

5.  A tissue engineered osteochondral plug: an in vitro morphological evaluation.

Authors:  C Scotti; M S Buragas; L Mangiavini; C Sosio; A Di Giancamillo; C Domeneghini; G Fraschini; G M Peretti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-06-27       Impact factor: 4.342

Review 6.  Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects.

Authors:  Christopher M Revell; Kyriacos A Athanasiou
Journal:  Tissue Eng Part B Rev       Date:  2009-03       Impact factor: 6.389

7.  Functional cartilage repair capacity of de-differentiated, chondrocyte- and mesenchymal stem cell-laden hydrogels in vitro.

Authors:  L Rackwitz; F Djouad; S Janjanin; U Nöth; R S Tuan
Journal:  Osteoarthritis Cartilage       Date:  2014-06-02       Impact factor: 6.576

8.  Effect of in vitro culture on a chondrocyte-fibrin glue hydrogel for cartilage repair.

Authors:  Celeste Scotti; Laura Mangiavini; Federica Boschetti; Francesca Vitari; Cinzia Domeneghini; Gianfranco Fraschini; Giuseppe M Peretti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-12-24       Impact factor: 4.342

9.  Similar properties of chondrocytes from osteoarthritis joints and mesenchymal stem cells from healthy donors for tissue engineering of articular cartilage.

Authors:  Amilton M Fernandes; Sarah R Herlofsen; Tommy A Karlsen; Axel M Küchler; Yngvar Fløisand; Jan E Brinchmann
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

10.  The immediate early gene product EGR1 and polycomb group proteins interact in epigenetic programming during chondrogenesis.

Authors:  Frank Spaapen; Guus G H van den Akker; Marjolein M J Caron; Peggy Prickaerts; Celine Rofel; Vivian E H Dahlmans; Don A M Surtel; Yvette Paulis; Finja Schweizer; Tim J M Welting; Lars M Eijssen; Jan Willem Voncken
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.